Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3522811 A
Publication typeGrant
Publication dateAug 4, 1970
Filing dateFeb 13, 1969
Priority dateFeb 13, 1969
Publication numberUS 3522811 A, US 3522811A, US-A-3522811, US3522811 A, US3522811A
InventorsSchwartz Seymour I, Wingrove Robert C
Original AssigneeMedtronic Inc
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Implantable nerve stimulator and method of use
US 3522811 A
Abstract  available in
Images(3)
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

United States Patent [72] Inventors: Seymour I. Schwartz Rochester, New York;

Robert C. Wingrove, Minneapolis, Minnesota [21] Application No.: 800,044

[22] Filed: Feb. 13, 1969 [45] Patented: Aug. 4, 1970 Continuation of Ser. No, 397,899, Sept. 21, 1964, now

' abandoned.

[73] Assignee: Medtronic, Inc., Minneapolis,

Minnesota (21 part interest) a corporation of Minnesota.

[54] IMPLANTABLE NERVE STIMULATOR AND METHOD OF USE 18 Claims, 13 Drawing Figs.

[52] 11.8. C1. 128/419 [51] Int. Cl. A61n H18 [50] Field ofSearch 128/2.1,

[56] References Cited UNITED STATES PATENTS 2,532,788 12/1950 Sarnoff 3,157,181 11/1964 McCarty 3,236,240 2/1966 Bradley 3,253,596 3/1966 Keller,.1r.

Primary Examiner- William E. Kamm Attorney-Lew Schwartz & Donald R. Stone ABSTRACT: An apparatus for stimulating the carotid sinus nerve, being entirely implantable in an animal, having a battery powered timed pulse producing circuit, a pair of electrodes adapted to be atraumatically connected to spaced points on the exterior surface of the nerve to be stimulated, and capacitive coupling between the electrodes and the pulse producing circuit to provide a substantially zero net DC current flow through the nerve.

Patented Aug. 4, 1970 3,522,811

Sheet 1 of 3 INVENTORS Sz na we Z Sara/4x72 BY P055427 6'. k/IAI6ROV6 US. PATENT 3,522,811 IMPLANTABLE NERVE STIMULATGR AND METHOD OF USE This application is a continuation of application Ser. No. 397,899, filed Sept. 21; 1964 and now abandoned.

This invention relates to a method and means for electrically stimulating the carotid sinus nerve to control blood pres sure in hypertensive persons, and more particularly to such means comprising an implantable stimulator atraumatically connected directly to the carotid sinus nerve to supplement carotid sinus nerve impulses with artificial electrical impulses which will be carried to the vasomotor center to control systemic blood pressure. As used herein, the word atraumatic has its normal meaning of not inflicting or causing damage or injury.

In some ninety percent of hypertensive patients, the cause of hypertension is unknown. However, it is known that in the human body there are baroreceptor areas which reflexly contribute to the control of systemic blood pressure. At least four of these major baroreceptor areas have been identified. In ad dition to the two that are located at the origin of the internal carotid arteries bilaterally (carotid sinuses), there are two situated in the aortic arch or in the major branches arising from this arch. It is known that in the hypertensive patient the baroreceptor mechanism located at the branching of the internal and external carotid sinus arteries do not function as they do in the normotensive person.

The carotid sinus baroreceptor endings are best considered as stretch receptors". These baroreceptors are nerve endings in the wall of the carotid artery just below the car on each side of the head. Their function is to cause impulses to be transmitted along the carotid sinus nerve whose frequency is in direct proportion to the stretching of the arterial walls, which in turn is proportional to the blood pressure within the artery. Physical deformation of the cellular wall probably affects an increasing negative depolarization of the cell membrane until the impulse threshold is reached and an action potential is produced. The frequency of these impulses is also somewhat dependent upon the rate of change of pressure within the artery. The carotid sinus nerve serves as the afferent limb of the baroreceptor reflex and transmits centrally to the vasomotor center those action potentials which arise from the carotid baroreceptors. These afferent impulses act centrally to inhibit sympathetic discharge by the vasomotor center and thereby secondarily affect vascular adjustments. The sympathetic nerves, which constitute the efferent limb, complete the carotid sinus reflex circuit and carry impulses which alter peripheral vascular resistance, cardiac output, and venous return.

An increase in the intraluminal pressure of the carotid baroreceptor reflexly, through the vasomotor center, lowers blood pressure, induces bradycardia, decreases cardiac output, and diminishes venous return. When the pressure within the baroreceptor is lowered, the converse situations are noted. The baroreceptor impulses, whose frequency is directly proportional to the intra-arterial pressure and to the rate of rise of this pressure within the baroreceptor organ, travel via the carotid sinus nerves to the hypothalamus area of the brain where they act upon the sympathetic nerve system which controls the diameters of various arteries and arterioles through the body.

In the normotensive person, the frequency ofthese impulses varies approximately from to 100 impulses per second as the pressure varies from 0 to 200mm ofmer'cury. In the hypertensive person, the baroreceptive centers-continue to be functional, but the threshold stimulus required to trigger the baroreceptor is significantly elevated. In chronic hypertension; there are'actually fewer impulses along the carotid sinus nerve than in the normotensive situation. .Thus, in the hypertensive person the baroreceptors'are essentially desensitized, in that the impulse frequency is lower for a given pressure than in the normotensive person.

In treating hypertensive patients, therefore, it is desirable to correct or artificially compensate for the desensitized baroreceptors. Surgical procedures directed at the reversal of hypertension have varied in their approach, but all have been concerned with counteracting an increased peripheral vascular resistance. More recently, attention has been directed away from the neurogenic factor and toward humoral factors eminating from the kidney. Renal artery reconstruction, in appropriate cases, and nephrectomy in others have had dramatic results, but these procedures are not applicable to all hypertensive patients. This invention of implantable artificial electrical means to selectively stimulate the carotid sinus nerve of the baroreceptor system provides a new approach to reducing systemic arterial hypertension. While the invention has been described as being applied to human beings, it could, of course, beadapted to reduce hypertension in other living animals. In fact, the preliminary experimental testing was conducted on dogs.

Electrical impulses for major organs of the body may be transmitted to that organ by means of pointed electrodes which penetrate the body of the organ and indirectly make contact with a nerve network without damaging the organ. Such general stimulation is not effective where the impulse must be superimposed on one particular nerve fiber and that fiber alone. The present structure is designed to transmit an electrical impulse specifically and solely to a surgically exposed carotid sinus nerve. Once the carotid sinus nerve has been exposed, the bipolar electrodes are placed around the nerve fiber and sewn closed to avoid penetration and damage to the nerve fiber itself. Because a net DC current would be destructive to the nerve and the electrodes, the present structure is designed to provide a substantially zero net DC current flow.

Artificial implantable stimulators in present use have been restricted in their use by reason of their size and bulk. The location of the carotid sinus nerve in the upper neck and head itself prevents implantation of presently used stimulators in the immediate area. The present invention which can operate on power from small rechargeable batteries within the stimulator unit occupies less than one-half the space of the cardiac pacemaker disclosed by Greatbatch. The present invention is of proper size to be seated within the limited confines of the mastoid cavity or locally just under the skin. Further, the present invention includes apparatus which prevents significant net DC current flow through the nerve.

It is a principal object of this invention to provide a practical method and means to artificially electrically stimulate the carotid sinus nerves to provide long-term supression of hypertension.

It is another object of this invention to provide an implantable stimulator which will provide long-term supresson of hypertension by artificially adding electrical impulses to the carotid sinus nerves with a net DC current flow through the nerves of substantially zero.

It is a further object of the present invention to provide a battery-powered implantable stimulator which will provide long'term suppression of hypertension by artificially adding electrical impulses to the carotid sinus nerves.

A still further object of this invention is to provide an implantable stimulator employing a recharge system to recharge the power supply located within the implantable stimulator.

It is a still further object of the invention to provide an implantable stimulator employing a portable recharge system to recharge the power supply located within the implantable stimulator.

In the drawings,

FIG. 1 is an elevational view of an implantable stimulator made according to the present invention;

FIG. 2 is a diagrammatic profile view of the head of a patient, partially in section, showing the relationship of a stimulator to the head when implanted in a mastoid cavity and connected to a carotid sinus nerve;

FIG. 3 is an enlarged fragmentary view of a portion of an implantable stimulator disclosing the stimulator electrodes in electrical contact with a carotid sinus nerve;

FIG. 4 is a sectional view taken on line 4 4 in FIG. 3;

FIG. is a view of an alternative shape of stimulator unit made according to the present invention;

FIG. 6 is a diagrammatic profile view of the head of a patient, partially in section, showing the relationship of the alternative shape stimulator unit of FIG. 5 implanted under the skin;

FIG. 7 is a view showing the recharging unit coil of FIG. 8 strapped in a position on a patients head for recharging;

FIG. 8 is a perspective view of a recharging unit including the recharging unit coil of FIG. 7;

FIG. 9 is a block diagram of an implantable stimulator pulse circuit deriving its power from rechargeable batteries.

FIG. I0 is a block diagram of an implantable stimulator pulse circuit deriving its power from replaceable batteries within the stimulator.

FIG. ll is a schematic circuit diagram showing a specific electrical pulse generating circuit of the present invention for use within a stimulator unit;

FIG. I2 is a block diagram of a stimulator recharging unit deriving its power from an A. C. line source; and

FIG. 13 is a block diagram of a portable stimulator recharging unit deriving its power from batteries.

Referring to the drawings and the numerals of reference thereon, in a first form of the invention as seen in FIGS. l, 2, 3

and 4 the implantable stimulator indicated generally at 1 which has been implanted under skin 2 in the mastoid cavity 3 of a hypertensive patient 4 comprises a pulse generating package 5 connected to electrodes 6 and 7 by flexible electrical conductors 8 and 9. The pulse generating package 5 is encased in a protective mass 13 composed of a synthetic resinous material such as silicon rubber which is compatible with the human body. The conductors are similarly encased in a protective sheath 10, and the electrodes 6 and 7 are partially similarly encased in protective covering 11. Electrodes 6 and 7 are partial cylindrical sections of an electrically conductive material compatible to the human body by being only partial cylinders, electrodes 6 and 7 define longitudinal apertures or slots large enough to receive nerve 12. Electrodes 6 and 7 are placed around exposed carotid sinus nerve 12 and pressed into electrical contact therewith. A flap 14 which is part of protective covering 11 is layed over the exposed portion of electrodes 6 and 7. Flap 14 makes contact with tab 15 which is also part of protective covering 11. Flap 14 is then sewn to tab 15 with surgical stitching 16 to firmly secure electrodes 6 and 7 to carotid sinus nerve l2 and to insulate electrodes 6 and 7 from other body tissues.

Referring to FIGS. 5 and 6 of the drawings, an alternative shape stimulator indicated generally at 21 is of thin construction as shown in FIG. 6 and is shown implanted under the skin 2 of a hypertensive patient 4 with electrodes 22 and 23 connected to the carotid sinus nerve 12.

Referring to FIG. 9 of the drawing, the implanted carotid sinus nerve stimulator is powered by rechargeable cells. lt can also be powered by a biological generator. Suitable rechargeable batteries 52 of this invention will operate continuously for approximately two weeks when fully charged. The battery power is supplied to an accurately timed pulse circuit 53 whose pulse output is directed through electrodes 6 and 7 to stimulate the carotid sinus nerve. The pulse output is capacitively coupled to electrodes 6 and 7 to block DC current flow from the nerve.

Referring to FIG. l0 ofthe drawings, a third type of stimulator unit which can be implanted inother areas such as the peetoral muscle or subcutaneously in the abdominal area, will be larger than those positioned in the area of the carotid sinus nerve and thus can be powered by replaceable primary batteries 48 such as mercury cells. This type of, stimulator has the disadvantage of requiring more extensive surgery and the'inconvenience of having long lead wires running subcutaneously up to the electrodes at the baroreceptor site. This type of unit of reasonable size using currently available mercury cells will operate approximately two years before battery replacement is necessary.

Referring to FIG. 11 of the drawings, a pulse circuit, indicated generally at 53, of the present invention is powered by battery 52. Battery 52 has one terminal connected to resistor 54, which is serially connected through capacitor 55 to base 56 of transistor 57. Battery 52 is also connected through a relatively large biasing resistor 58 to base 56 of transistor 57. Battery 52 is also connected directly to emitter 59 of transistor 57. The common junction of biasing resistor 58, capacitor 55, and base 56 of transistor 57 is connected through biasing resistor 60 to the second terminal of battery 52. Collector 61 of transistor 57 is connected through current limiting resistor 62 to the base 63 of transistor 64. Collector of transistor 64 is connected to the common junction of resistor 54 and capacitor 55. Storage capacitor 66 is serially connected between collector 65 and carotid sinus nerve electrode 6. Emitter 67 of transistor 64 is connected directly to carotid sinus nerve electrode 7 and to the battery side of biasing resistance 60.

With voltage of battery 52 impressed upon the circuit storage capacitor 66 will begin to charge through the circuit consisting of battery 52, resistor 54, electrodes 6 and 7, and the output load resistance comprising nerve 12 until collector 65 of transistor 64 reaches positive potential of battery 52 with respect to electrode 7. Between pulses collector 65 remains nearly at battery 52 potential with respect to electrode 7. The circuit 53 may be described as a free-running complementary multivibrator. A complete cycle of operation may be described as follows:

Biasing resistors 60 and 58, which form a voltage divider cause a small current to begin flowing through transistor 57, current limiting resistor 62, from base 63 to emitter 67 of transistor 64 and through battery 52. This small current is amplified by transistor 64 and current flows through resistor 54 causing the potential on collector 65 to lower with respect to the reference potential on electrode 7. The change in potential on collector 65 is coupled through capacitor 55 to base 56 of transistor 57 and causes an increase in condition of transistor 57 thereby leading to a further increase in conduction of transistor 64 and a further lowering of the potential on collector 65. Thus, capacitor 55 provides a positive feedback path which quickly results in saturation of transistor 64. After saturation of transistor 64, capacitor 55 becomes fully charged through the current path comprising emitter 59 and base 56 of transistor 57 and collector 65 and emitter 67 of transistor 64. At this point, with current no longer flowing through capacitor 55, transistor 57 begins to return to its original low conductive state provided by biasing resistors 60 and 58. However, as collector 65 of transistor 64 returns toward the positive battery potential because of the decrease in current through resistor 54, the charge on capacitor 55 completely cuts off transistor 57. Since no current is then flowing through resistor 62 to base 63 of transistor 64, transistor 64 is also completely cut off. Both transistors remain in the non-conducting state until capacitor 55 has discharged sufficiently through resistors 58 and 54 to allow biasing resistors 60 and 58 to bring transistor 57 into a conductive state and the cycle begins again. The stimulation output pulse occurs during the time transistor 64 is conducting, when storage capacitor 66 discharges through collector 65 and emitter 67 of transistor 64, through electrode I 7, the nerve, and back via electrode 6. Pulse width and pulse recurrence frequency are determined by the size of capacitor 55 and resistors 58 and 54, as well as by biasing resistor 60. The presence of capacitor 66, connected serially in the lead to electrode 6, makes the net DC current flow substantially zero for a complete cycle.

In actual use the circuit of FIG. 1 1 can be adjusted to produce a pulse amplitude of 0.5 to 5 volts, a pulse recurrence frequency of 60-100 pulses per second, and a pulse width from -200 microseconds with a battery voltage of 5 volts. While a specific circuit is shown, the pulse circuit can be any low current pulse circuit which produces no current during the off period.

Referring to FIGS. 7 and 8 of the drawings, a stimulator recharging unit indicated generally at 27 includes a radio frequency oscillator unit 28 electrically connected by insulated wire 29 to the primary recharging coil 30 encased in a suitable protective casing 31. When it is desired to recharge the battery 52 located within implantable stimulator unit 1 or 21 which has been implanted in the patient 4, the energized primary recharging coil 30 is placed in close proximity to the secondary recharging coil 42 located in implantable stimulator unit 1 or 21. Primary recharging coil 30 may be worn in a head band 32 or may be placed in proper position on or within a pillow, to accomplish recharging while the patient sleeps or rests.

Referring to FIGS. 9 and 1 l of the drawings, the battery 52 ofthe stimulator unit 1 may be periodically recharged by electromagnetic induction in secondary recharging coil 42 due to an electromagnetic field established by primary recharging coil 30 of FIG. 8. The radio frequency signal induced in the secondary recharging coil 42 is rectified by the rectifier circuit 43 including diode 44 and capacitor 45. The rectifier circuit output is coupled to battery 52 through resistor 56 and filtering capacitor 47.

Referring to FIGS. 12 and i3 of the drawings, the primary recharging coil 30 is energized by connection either to an alternating current power source 33 through a rectifier unit 24 and a radio frequency oscillator unit 28, or alternatively to batteries 34 and through a radio frequency oscillator 28.

We claim:

1. Apparatus for electrical stimulation of a selected nerve of an animal comprising: electrical circuit means including electrical output means; electrode means for atraumatic connection to the external surface of the nerve to be stimulated; electrically conductive means connecting said electrode means to said output means; said output means including means for producing a substantially zero net DC current flow through the nerve; said electrode means, said electrically conductive means and at least a portion of said electrical circuit means adapted to be implanted in the animal; and at least said portion of said electrical circuit means, at least a portion of said electrode means and said electrically conductive means covered by an electrically insulating substance substantially inert to body fluids and tissue.

2. The apparatus of Claim 1 in which: said electrode means comprises at least a pair of electrodes adapted to be connected to the external surface of the nerve in spaced relation.

3. The apparatus of Claim 2 in which: said electrodes each comprise a generally flat, electrically conductive material substantially inert to body fluids and tissue, and generally conformable to the external surface of the nerve.

4. The apparatus of Claim 1 in which: said means for producing a substantially zero net DC current flow comprises capacitance means connected intermediate at least a portion of said electrically conductive means and said electrical circuit means.

5. Apparatus for electrical stimulation of a selected nerve in an animal, the apparatus adapted to be-surgically implanted in the animal, comprising: first means for providing a timed electrical pulse; second means for producing a substantially zero net DC current flow; electrode means for atraumatic connection to the external surface of the nerve; said electrode means connected to said first means by said second means for producing a substantially zero net DC current flow through the nerve; and said first and second means and at least part of said electrode means being encapsulated in a substance substantially inert to body fluids and tissue. 1

6. The apparatus of Claim 5 in which said second means comprises a capacitor serially connected between said first means and at least a portion of said electrode means.

7. The apparatus of Claim 5 in which: said electrode means comprise at least a pair of electrodes adapted to be connected to the external surface of the nerve in spaced relation.

8. The apparatus of Claim 7 in which said electrodes each comprise: a generally flat, electrically conductive material substantially inert to body fluids and tissue; said material curving to form a partial cylinder defining an axial aperture extending the length of said cylinder; and said aperture being of sufficient width to permit atraumatic passage of a portion of the nerve therethrough.

9. The apparatus of Claim 5 in which said substance encapsulating at least a part of said electrodes includes: a further portion of said substance integral with said substance; said further portion adated to be folded over the exposed part of said electrodes when they are connected to the nerve, and fastened in the folded position.

10. Apparatus for electrical stimulation of a selected nerve of an animal and adapted to be implanted in the animal comprising: a timed electrical pulse producing circuit; a pair of spaced electrode means for atraumatic connection to the nerve, said electrode means adapted to be positioned in electrically conducting relation to the exterior surface of the nerve; electrical conducting means connecting said pulse producing circuit and one of said electrode means; capacitance means serially connected between said pulse producing circuit and the other of said electrode means; a non-toxic, non-irritant protective covering encasing said electrical conducting means, said capacitance means, and said pulse producing circuit; and said covering including a first member at least partially encompassing said spaced electrode means and a second member for encompassing at least that part of the nerve adapted to be positioned between said electrode means.

11. The apparatus of Claim 10 in which: said electrode means comprise partial cylinders of non-toxic, non-irritant electrically conducting material; and each of said electrode means include a longitudinally extending slot extending from the length of said cylinder and at least initially dimensioned to permit atraumatic passage of the nerve therethrough.

12. The apparatus ofClaim 10 in which said timed electrical pulse producing circuit includes; battery means: a first transistor having first emitter, collector and base electrodes; a second transistor having second emitter, collector and base electrodes; voltage divider means connected across said battery; said first base electrode connected to said voltage divider means; said first emitter electrode connected to one terminal of said battery; said second emitter electrode connected to the other terminal of said battery; impedance means connecting said first collector electrode to said second base electrode; impedance means connecting said first emitter electrode to said second collector electrode; further capacitance means connected between said first base electrode and said second collector electrode; said second collector electrode connected to said capacitance means; and said second emitter electrode connected to said one of said pair of spaced electrode means.

13. The apparatus of Claim 12 in which said pulse producing circuit includes a battery charging circuit connected to said battery means comprising: a secondary electromagnetic induction coil; rectifier means; further electrical conducting means connecting said secondary coil to said rectifier means and said rectifier means to said battery means; and said secondary coil, said rectifier means and said further electrical conducting means adapted to be implanted in the animal and encased in said protective covering.

14. The apparatus of Claim 13 including means external to said animal for providing energy to the battery charging circuit comprising: electromagnetic induction means including a primary electromagnetic induction coil adapted to be placed external to said animal in inductive relation to said implanted secondary electromagnetic induction coil.

15. The method of stimulation ofa selected nerve in a living animal including the steps of: implanting an electrical circuit in the animal; connecting at least a pair of electrodes to the electrical circuit; atraumatically attaching the electrodes to spaced points on the exterior surface of the nerve; energizing the electrical circuit to apply timed stimulating electrical pulses to the nerve of a magnitude sufficient to trigger the nerve for increasing the impulse frequency of the nerve; and sub C. atraumatically coupling the modified pulses to each carotid sinus nerve of the animal.

17. The method of Claim 16 including the step of atraumatically coupling the modified pulses to each carotid sinus nerve of the animal.

18. The method of Claim 16 including the step ofatraumatically coupling the modified pulses to a carotid sinus nerve through bipolar electrodes.

Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3724467 *Apr 23, 1971Apr 3, 1973Avery Labor IncElectrode implant for the neuro-stimulation of the spinal cord
US4509521 *Jan 31, 1983Apr 9, 1985Barry Terrence JHeadache relief method
US4640286 *Nov 2, 1984Feb 3, 1987Staodynamics, Inc.Optimized nerve fiber stimulation
US4803988 *Feb 2, 1987Feb 14, 1989Staodynamics, Inc.Nerve fiber stimulation using plural equally active electrodes
US4813418 *Feb 2, 1987Mar 21, 1989Staodynamics, Inc.Nerve fiber stimulation using symmetrical biphasic waveform applied through plural equally active electrodes
US5038781 *Apr 19, 1990Aug 13, 1991Hassan HamediMulti-electrode neurological stimulation apparatus
US5330507 *Apr 24, 1992Jul 19, 1994Medtronic, Inc.Implantable electrical vagal stimulation for prevention or interruption of life threatening arrhythmias
US5571150 *Dec 19, 1994Nov 5, 1996Cyberonics, Inc.Treatment of patients in coma by nerve stimulation
US5578061 *Oct 3, 1995Nov 26, 1996Pacesetter AbMethod and apparatus for cardiac therapy by stimulation of a physiological representative of the parasympathetic nervous system
US5700282 *Oct 13, 1995Dec 23, 1997Zabara; JacobHeart rhythm stabilization using a neurocybernetic prosthesis
US5792067 *Mar 13, 1996Aug 11, 1998Karell; Manuel L.For providing electrical stimulation to tissue in the mouth
US6073048 *Nov 17, 1995Jun 6, 2000Medtronic, Inc.Baroreflex modulation with carotid sinus nerve stimulation for the treatment of heart failure
US6366815 *Jan 13, 1998Apr 2, 2002Neurodan A /SImplantable nerve stimulator electrode
US6850801Sep 26, 2001Feb 1, 2005Cvrx, Inc.Mapping methods for cardiovascular reflex control devices
US6985774Sep 26, 2001Jan 10, 2006Cvrx, Inc.Stimulus regimens for cardiovascular reflex control
US6997952 *Jul 12, 2004Feb 14, 2006Nec Tokin CorporationArtificial sphincter
US7079977Oct 15, 2003Jul 18, 2006Medtronic, Inc.Synchronization and calibration of clocks for a medical device and calibrated clock
US7146211Oct 15, 2003Dec 5, 2006Medtronic, Inc.Signal quality monitoring and control for a medical device system
US7149572Oct 15, 2003Dec 12, 2006Medtronic, Inc.Phase shifting of neurological signals in a medical device system
US7158832 *Sep 26, 2001Jan 2, 2007Cvrx, Inc.Electrode designs and methods of use for cardiovascular reflex control devices
US7162303Apr 8, 2003Jan 9, 2007Ardian, Inc.Renal nerve stimulation method and apparatus for treatment of patients
US7209787 *Nov 20, 2003Apr 24, 2007Bioneuronics CorporationApparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US7212864Dec 9, 2003May 1, 2007Medtronic, Inc.Modular implantable medical device
US7218964Oct 26, 2001May 15, 2007Medtronic, Inc.Closed-loop neuromodulation for prevention and treatment of cardiac conditions
US7231254Jul 12, 2004Jun 12, 2007Bioneuronics CorporationClosed-loop feedback-driven neuromodulation
US7242982Dec 9, 2003Jul 10, 2007Medtronic, Inc.Overmold for a modular implantable medical device
US7242983Oct 15, 2003Jul 10, 2007Medtronic, Inc.Channel-selective blanking for a medical device system
US7242984Jan 6, 2004Jul 10, 2007Neurovista CorporationApparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US7263401Apr 29, 2004Aug 28, 2007Medtronic, Inc.Implantable medical device with a nonhermetic battery
US7277758Apr 5, 2004Oct 2, 2007Neurovista CorporationMethods and systems for predicting future symptomatology in a patient suffering from a neurological or psychiatric disorder
US7282030Oct 15, 2003Oct 16, 2007Medtronic, Inc.Timed delay for redelivery of treatment therapy for a medical device system
US7317947Apr 29, 2004Jan 8, 2008Medtronic, Inc.Headset recharger for cranially implantable medical devices
US7321837Feb 15, 2006Jan 22, 2008Medtronic, Inc.Synchronization and calibration of clocks for a medical device and calibrated clock
US7324851Jun 1, 2004Jan 29, 2008Neurovista CorporationClosed-loop feedback-driven neuromodulation
US7395119May 19, 2005Jul 1, 2008Cvrx, Inc.Implantable electrode assembly having reverse electrode configuration
US7403820May 25, 2005Jul 22, 2008Neurovista CorporationClosed-loop feedback-driven neuromodulation
US7450994Dec 16, 2004Nov 11, 2008Advanced Bionics, LlcEstimating flap thickness for cochlear implants
US7460906Dec 24, 2003Dec 2, 2008Cardiac Pacemakers, Inc.Baroreflex stimulation to treat acute myocardial infarction
US7499742Mar 27, 2003Mar 3, 2009Cvrx, Inc.Electrode structures and methods for their use in cardiovascular reflex control
US7596399Apr 29, 2004Sep 29, 2009Medtronic, IncImplantation of implantable medical device
US7596408Apr 30, 2004Sep 29, 2009Medtronic, Inc.Implantable medical device with anti-infection agent
US7596413Jun 8, 2004Sep 29, 2009Cardiac Pacemakers, Inc.Coordinated therapy for disordered breathing including baroreflex modulation
US7616997Mar 27, 2003Nov 10, 2009Kieval Robert SDevices and methods for cardiovascular reflex control via coupled electrodes
US7617005Aug 14, 2006Nov 10, 2009Ardian, Inc.Methods and apparatus for thermally-induced renal neuromodulation
US7620451Feb 27, 2006Nov 17, 2009Ardian, Inc.Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
US7623926Apr 5, 2004Nov 24, 2009Cvrx, Inc.Stimulus regimens for cardiovascular reflex control
US7623928May 2, 2007Nov 24, 2009Neurovista CorporationControlling a subject's susceptibility to a seizure
US7624293Feb 15, 2006Nov 24, 2009Medtronic, Inc.Synchronization and calibration of clocks for a medical device and calibrated clock
US7643875Dec 24, 2003Jan 5, 2010Cardiac Pacemakers, Inc.Baroreflex stimulation system to reduce hypertension
US7647114Sep 13, 2004Jan 12, 2010Cardiac Pacemakers, Inc.Baroreflex modulation based on monitored cardiovascular parameter
US7647115Jun 3, 2005Jan 12, 2010Ardian, Inc.Renal nerve stimulation method and apparatus for treatment of patients
US7653438May 13, 2005Jan 26, 2010Ardian, Inc.Methods and apparatus for renal neuromodulation
US7657312Nov 3, 2003Feb 2, 2010Cardiac Pacemakers, Inc.Multi-site ventricular pacing therapy with parasympathetic stimulation
US7676263Jun 21, 2007Mar 9, 2010Neurovista CorporationMinimally invasive system for selecting patient-specific therapy parameters
US7706884 *Dec 24, 2003Apr 27, 2010Cardiac Pacemakers, Inc.Baroreflex stimulation synchronized to circadian rhythm
US7715919Oct 15, 2003May 11, 2010Medtronic, Inc.Control of treatment therapy during start-up and during operation of a medical device system
US7717948Aug 16, 2007May 18, 2010Ardian, Inc.Methods and apparatus for thermally-induced renal neuromodulation
US7747323Jun 8, 2004Jun 29, 2010Cardiac Pacemakers, Inc.Adaptive baroreflex stimulation therapy for disordered breathing
US7747325Sep 28, 2005Jun 29, 2010Neurovista CorporationSystems and methods for monitoring a patient's neurological disease state
US7758568May 27, 2004Jul 20, 2010Medtronic, Inc.Implantable therapeutic substance delivery device
US7769441Nov 3, 2005Aug 3, 2010The Board Of Regents Of The University Of OklahomaCardiac neuromodulation and methods of using same
US7783353Nov 9, 2006Aug 24, 2010Cardiac Pacemakers, Inc.Automatic neural stimulation modulation based on activity and circadian rhythm
US7801614Oct 23, 2006Sep 21, 2010Cvrx, Inc.Stimulus regimens for cardiovascular reflex control
US7813812Jul 7, 2006Oct 12, 2010Cvrx, Inc.Baroreflex stimulator with integrated pressure sensor
US7840271Jul 20, 2005Nov 23, 2010Cvrx, Inc.Stimulus regimens for cardiovascular reflex control
US7840279Feb 11, 2005Nov 23, 2010Boston Scientific Neuromodulation CorporationImplantable microstimulator having a separate battery unit and methods of use thereof
US7853329Dec 29, 2006Dec 14, 2010Neurovista CorporationMonitoring efficacy of neural modulation therapy
US7853333Jun 12, 2006Dec 14, 2010Ardian, Inc.Methods and apparatus for multi-vessel renal neuromodulation
US7860563Nov 23, 2005Dec 28, 2010The Board Of Regents Of The University Of OklahomaCardiac neuromodulation and methods of using same
US7881796Jul 31, 2007Feb 1, 2011Medtronic, Inc.Implantable medical device with a nonhermetic battery
US7894907Jun 18, 2007Feb 22, 2011Ebr Systems, Inc.Systems and methods for implantable leadless nerve stimulation
US7917206Nov 7, 2006Mar 29, 2011Medtronic, Inc.Signal quality monitoring and control for a medical device system
US7920924Oct 2, 2008Apr 5, 2011Advanced Bionics, LlcEstimating flap thickness for cochlear implants
US7925352Mar 27, 2009Apr 12, 2011Synecor LlcSystem and method for transvascularly stimulating contents of the carotid sheath
US7930035May 2, 2007Apr 19, 2011Neurovista CorporationProviding output indicative of subject's disease state
US7933646Aug 13, 2007Apr 26, 2011Medtronic, Inc.Clustering of recorded patient neurological activity to determine length of a neurological event
US7937143Oct 18, 2005May 3, 2011Ardian, Inc.Methods and apparatus for inducing controlled renal neuromodulation
US7949395 *Jan 27, 2003May 24, 2011Boston Scientific Neuromodulation CorporationImplantable microdevice with extended lead and remote electrode
US7949400Nov 10, 2009May 24, 2011Cvrx, Inc.Devices and methods for cardiovascular reflex control via coupled electrodes
US7962222 *Oct 19, 2006Jun 14, 2011Boston Scientific Neuromodulation CorporationBattery protection and zero-volt battery recovery system for an implantable medical device
US7976465Oct 17, 2006Jul 12, 2011Medtronic, IncPhase shifting of neurological signals in a medical device system
US8000793May 23, 2008Aug 16, 2011Cardiac Pacemakers, Inc.Automatic baroreflex modulation based on cardiac activity
US8005539Jan 30, 2009Aug 23, 2011Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US8024050Dec 24, 2003Sep 20, 2011Cardiac Pacemakers, Inc.Lead for stimulating the baroreceptors in the pulmonary artery
US8032220Mar 22, 2011Oct 4, 2011Boston Scientific Neuromodulation CorporationMethod of implanting microdevice with extended lead and remote electrode
US8036736Mar 21, 2008Oct 11, 2011Neuro Vista CorporationImplantable systems and methods for identifying a contra-ictal condition in a subject
US8060206 *Jul 7, 2006Nov 15, 2011Cvrx, Inc.Baroreflex modulation to gradually decrease blood pressure
US8060215Jul 7, 2010Nov 15, 2011Boston Scientific Neuromodulation CorporationImplantable microstimulator having a battery unit and methods of use therefor
US8086313Aug 5, 2009Dec 27, 2011Medtronic, Inc.Implantable medical device with anti-infection agent
US8086314Oct 29, 2002Dec 27, 2011Cvrx, Inc.Devices and methods for cardiovascular reflex control
US8109879Jan 10, 2006Feb 7, 2012Cardiac Pacemakers, Inc.Assessing autonomic activity using baroreflex analysis
US8116883Feb 2, 2007Feb 14, 2012Synecor LlcIntravascular device for neuromodulation
US8121693Oct 23, 2008Feb 21, 2012Cardiac Pacemakers, Inc.Baroreflex stimulation to treat acute myocardial infarction
US8126560Dec 24, 2003Feb 28, 2012Cardiac Pacemakers, Inc.Stimulation lead for stimulating the baroreceptors in the pulmonary artery
US8131362Aug 19, 2009Mar 6, 2012Cardiac Pacemakers, Inc.Combined neural stimulation and cardiac resynchronization therapy
US8131371Apr 13, 2006Mar 6, 2012Ardian, Inc.Methods and apparatus for monopolar renal neuromodulation
US8131372Mar 19, 2007Mar 6, 2012Ardian, Inc.Renal nerve stimulation method for treatment of patients
US8131373Mar 30, 2010Mar 6, 2012Cardiac Pacemakers, Inc.Baroreflex stimulation synchronized to circadian rhythm
US8145316Jul 25, 2005Mar 27, 2012Ardian, Inc.Methods and apparatus for renal neuromodulation
US8145317Mar 6, 2006Mar 27, 2012Ardian, Inc.Methods for renal neuromodulation
US8150518Jun 3, 2005Apr 3, 2012Ardian, Inc.Renal nerve stimulation method and apparatus for treatment of patients
US8150519Mar 6, 2006Apr 3, 2012Ardian, Inc.Methods and apparatus for bilateral renal neuromodulation
US8150520Mar 6, 2006Apr 3, 2012Ardian, Inc.Methods for catheter-based renal denervation
US8175711Mar 6, 2006May 8, 2012Ardian, Inc.Methods for treating a condition or disease associated with cardio-renal function
US8187181Oct 15, 2003May 29, 2012Medtronic, Inc.Scoring of sensed neurological signals for use with a medical device system
US8195289Nov 30, 2009Jun 5, 2012Cardiac Pacemakers, Inc.Baroreflex stimulation system to reduce hypertension
US8224437Oct 3, 2008Jul 17, 2012Cvrx, Inc.Baroreflex activation for sedation and sleep
US8249708Jan 30, 2009Aug 21, 2012Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US8260412Jan 30, 2009Sep 4, 2012Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US8280478Aug 10, 2009Oct 2, 2012Medtronic, Inc.Evaluation of implantation site for implantation of implantable medical device
US8285389Jul 21, 2010Oct 9, 2012Cardiac Pacemakers, Inc.Automatic neural stimulation modulation based on motion and physiological activity
US8290595Jul 7, 2006Oct 16, 2012Cvrx, Inc.Method and apparatus for stimulation of baroreceptors in pulmonary artery
US8295934Nov 14, 2006Oct 23, 2012Neurovista CorporationSystems and methods of reducing artifact in neurological stimulation systems
US8315713Apr 30, 2009Nov 20, 2012Medtronic, Inc.Techniques for placing medical leads for electrical stimulation of nerve tissue
US8326431Apr 28, 2006Dec 4, 2012Medtronic, Inc.Implantable medical device for the concurrent treatment of a plurality of neurological disorders and method therefore
US8347891Nov 14, 2006Jan 8, 2013Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US8369954Mar 7, 2011Feb 5, 2013Synecor LlcSystem and method for transvascularly stimulating contents of the carotid sheath
US8397732Dec 9, 2003Mar 19, 2013Medtronic, Inc.Implantation of low-profile implantable medical device
US8417334Oct 26, 2001Apr 9, 2013Medtronic, Inc.Method and apparatus for electrically stimulating the nervous system to improve ventricular dysfunction, heart failure, and other cardiac conditions
US8433423Dec 13, 2010Apr 30, 2013Ardian, Inc.Methods for multi-vessel renal neuromodulation
US8442638May 17, 2010May 14, 2013Cardiac Pacemakers, Inc.Adaptive baroreflex stimulation therapy for disordered breathing
US8442640Jan 4, 2010May 14, 2013Cardiac Pacemakers, Inc.Neural stimulation modulation based on monitored cardiovascular parameter
US8444640Sep 14, 2012May 21, 2013Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US8452394Jan 30, 2009May 28, 2013Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US8454594Aug 11, 2009Jun 4, 2013Medtronic Ardian Luxembourg S.A.R.L.Apparatus for performing a non-continuous circumferential treatment of a body lumen
US8457746Aug 4, 2011Jun 4, 2013Cardiac Pacemakers, Inc.Implantable systems and devices for providing cardiac defibrillation and apnea therapy
US8473057Oct 30, 2009Jun 25, 2013Medtronic, Inc.Shunt-current reduction housing for an implantable therapy system
US8473076Sep 6, 2011Jun 25, 2013Cardiac Pacemakers, Inc.Lead for stimulating the baroreceptors in the pulmonary artery
US8478414Apr 30, 2008Jul 2, 2013Cvrx, Inc.Baroreflex activation for pain control, sedation and sleep
US8494643Jan 18, 2011Jul 23, 2013Ebr Systems, Inc.Systems and methods for implantable leadless nerve stimulation
US8498698Aug 31, 2009Jul 30, 2013Medtronic, Inc.Isolation of sensing and stimulation circuitry
US8527045Oct 30, 2009Sep 3, 2013Medtronic, Inc.Therapy system including cardiac rhythm therapy and neurostimulation capabilities
US8532779Jan 30, 2009Sep 10, 2013Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US8532793Apr 30, 2009Sep 10, 2013Medtronic, Inc.Techniques for placing medical leads for electrical stimulation of nerve tissue
US8535222Mar 13, 2007Sep 17, 2013Cardiac Pacemakers, Inc.Sleep detection using an adjustable threshold
US8543199Sep 2, 2011Sep 24, 2013Cyberonics, Inc.Implantable systems and methods for identifying a contra-ictal condition in a subject
US8543214Oct 15, 2003Sep 24, 2013Medtronic, Inc.Configuring and testing treatment therapy parameters for a medical device system
US8548600Sep 14, 2012Oct 1, 2013Medtronic Ardian Luxembourg S.A.R.L.Apparatuses for renal neuromodulation and associated systems and methods
US8551069Mar 6, 2006Oct 8, 2013Medtronic Adrian Luxembourg S.a.r.l.Methods and apparatus for treating contrast nephropathy
US8560060Aug 31, 2009Oct 15, 2013Medtronic, Inc.Isolation of sensing and stimulation circuitry
US8560076Nov 5, 2010Oct 15, 2013Cvrx, Inc.Devices and methods for electrode implantation
US8571655Jan 26, 2010Oct 29, 2013Cardiac Pacemakers, Inc.Multi-site ventricular pacing therapy with parasympathetic stimulation
US8579786Oct 15, 2003Nov 12, 2013Medtronic, Inc.Screening techniques for management of a nervous system disorder
US8583236Mar 8, 2010Nov 12, 2013Cvrx, Inc.Devices and methods for cardiovascular reflex control
US8588933Jan 11, 2010Nov 19, 2013Cyberonics, Inc.Medical lead termination sleeve for implantable medical devices
US8594794Jul 17, 2008Nov 26, 2013Cvrx, Inc.Baroreflex activation therapy with incrementally changing intensity
US8594798Oct 15, 2003Nov 26, 2013Medtronic, Inc.Multi-modal operation of a medical device system
US8606356Aug 17, 2004Dec 10, 2013Cardiac Pacemakers, Inc.Autonomic arousal detection system and method
US8606359Apr 13, 2007Dec 10, 2013Cvrx, Inc.System and method for sustained baroreflex stimulation
US8611996Jan 30, 2009Dec 17, 2013Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US8620423Mar 14, 2011Dec 31, 2013Medtronic Ardian Luxembourg S.A.R.L.Methods for thermal modulation of nerves contributing to renal function
US8626300Mar 11, 2011Jan 7, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for thermally-induced renal neuromodulation
US8626301Jun 3, 2013Jan 7, 2014Cardiac Pacemakers, Inc.Automatic baroreflex modulation based on cardiac activity
US8639322May 30, 2012Jan 28, 2014Cardiac Pacemakers, Inc.System and method for delivering myocardial and autonomic neural stimulation
US8684998Mar 9, 2012Apr 1, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods for inhibiting renal nerve activity
US8688210Jan 30, 2009Apr 1, 2014Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US8712531May 24, 2012Apr 29, 2014Cvrx, Inc.Automatic baroreflex modulation responsive to adverse event
US8718789Apr 19, 2010May 6, 2014Cvrx, Inc.Electrode structures and methods for their use in cardiovascular reflex control
US8721637Jul 12, 2013May 13, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for performing renal neuromodulation via catheter apparatuses having inflatable balloons
US8725243Dec 28, 2005May 13, 2014Cyberonics, Inc.Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
US8728137Feb 12, 2013May 20, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods for thermally-induced renal neuromodulation
US8728138Feb 12, 2013May 20, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods for thermally-induced renal neuromodulation
US8738136Aug 13, 2007May 27, 2014Medtronic, Inc.Clustering of recorded patient neurological activity to determine length of a neurological event
US8740896Jul 12, 2013Jun 3, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for performing renal neuromodulation via catheter apparatuses having inflatable balloons
US8755907May 21, 2013Jun 17, 2014Cvrx, Inc.Devices and methods for electrode implantation
US8762065Jun 22, 2005Jun 24, 2014Cyberonics, Inc.Closed-loop feedback-driven neuromodulation
US8768470May 11, 2010Jul 1, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods for monitoring renal neuromodulation
US8771252May 20, 2005Jul 8, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods and devices for renal nerve blocking
US8774913Nov 14, 2006Jul 8, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for intravasculary-induced neuromodulation
US8774918Jan 30, 2009Jul 8, 2014Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US8774922May 21, 2013Jul 8, 2014Medtronic Ardian Luxembourg S.A.R.L.Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods
US8781597May 5, 2010Jul 15, 2014Cyberonics, Inc.Systems for monitoring a patient's neurological disease state
US8784463Feb 12, 2013Jul 22, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods for thermally-induced renal neuromodulation
US8786624Jun 2, 2010Jul 22, 2014Cyberonics, Inc.Processing for multi-channel signals
US8805501Jan 25, 2012Aug 12, 2014Cardiac Pacemakers, Inc.Baroreflex stimulation to treat acute myocardial infarction
US8805513Apr 23, 2013Aug 12, 2014Cardiac Pacemakers, Inc.Neural stimulation modulation based on monitored cardiovascular parameter
US8805545Apr 16, 2013Aug 12, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for multi-vessel renal neuromodulation
US8818513Mar 1, 2012Aug 26, 2014Cardiac Pacemakers, Inc.Baroreflex stimulation synchronized to circadian rhythm
US8818514Jul 2, 2013Aug 26, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods for intravascularly-induced neuromodulation
US8838246Sep 27, 2006Sep 16, 2014Cvrx, Inc.Devices and methods for cardiovascular reflex treatments
USRE36120 *Feb 7, 1996Mar 2, 1999Karell; Manuel L.Snopper--the snoring stopper anti-snoring mouth device
EP0854742A1 *Oct 9, 1996Jul 29, 1998Jacob ZabaraHeart rhythm stabilization using a neurocybernetic prosthesis
EP2085114A2 *Sep 27, 2001Aug 5, 2009CVRX, Inc.Devices and methods for cardiovascular reflex control
EP2399644A2 *Sep 27, 2001Dec 28, 2011CVRX, Inc.Devices for cardiovascular reflex control
WO2003076008A1Mar 13, 2003Sep 18, 2003Brainsgate LtdTechnique for blood pressure regulation
WO2005051306A2 *Nov 19, 2004Jun 9, 2005Daniel John DilorenzoApparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
Classifications
U.S. Classification607/27, 607/44, 607/72, 607/61
International ClassificationA61N1/372
Cooperative ClassificationA61N1/372
European ClassificationA61N1/372